Biocryst Pharmaceuticals reported $85.58M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Chemocentryx CCXI:US $ 39.55M 1M
Chugai Pharma 4519:JP 165.11B 40.41B
Daiichi Sankyo 4568:JP 226.92B 8.62B
Enanta Pharmaceuticals ENTA:US $ 57.3M 1.83M
Gilead Sciences GILD:US $ 3579M 392M
Glaxosmithkline GSK:US 7.14B 722M
GlaxoSmithKline GSK:LN 7.14B 722M
Intra Cellular Therapies ITCI:US $ 99.53M 10.34M
IONIS PHARMACEUT IONS:US $ 219M 11.65M
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novavax NVAX:US $ 485.99M 157.86M
Ptc Therapeutics PTCT:US $ 231.82M 16.65M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M
YTE INCY:US $ 577.58M 12.7M
Zogenix ZGNX:US $ 76.48M 2.26M